IRIS Accounts Production v24.3.0.553 07200710 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072007102023-03-31072007102024-03-31072007102023-04-012024-03-31072007102022-03-31072007102022-04-012023-03-31072007102023-03-3107200710ns15:EnglandWales2023-04-012024-03-3107200710ns14:PoundSterling2023-04-012024-03-3107200710ns10:Director12023-04-012024-03-3107200710ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107200710ns10:SmallEntities2023-04-012024-03-3107200710ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107200710ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107200710ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107200710ns10:FullAccounts2023-04-012024-03-310720071012023-04-012024-03-3107200710ns10:OrdinaryShareClass12023-04-012024-03-3107200710ns10:OrdinaryShareClass22023-04-012024-03-3107200710ns5:CurrentFinancialInstruments2024-03-3107200710ns5:CurrentFinancialInstruments2023-03-3107200710ns5:ShareCapital2024-03-3107200710ns5:ShareCapital2023-03-3107200710ns5:RetainedEarningsAccumulatedLosses2024-03-3107200710ns5:RetainedEarningsAccumulatedLosses2023-03-3107200710ns10:RegisteredOffice2023-04-012024-03-3107200710ns5:NetGoodwill2023-04-012024-03-3107200710ns5:NetGoodwill2023-03-3107200710ns5:NetGoodwill2024-03-3107200710ns5:NetGoodwill2023-03-3107200710ns5:FurnitureFittings2023-03-3107200710ns5:MotorVehicles2023-03-3107200710ns5:FurnitureFittings2023-04-012024-03-3107200710ns5:MotorVehicles2023-04-012024-03-3107200710ns5:FurnitureFittings2024-03-3107200710ns5:MotorVehicles2024-03-3107200710ns5:FurnitureFittings2023-03-3107200710ns5:MotorVehicles2023-03-3107200710ns10:OrdinaryShareClass12024-03-3107200710ns10:OrdinaryShareClass22024-03-31072007101ns10:Director12023-03-31072007101ns10:Director12022-03-31072007101ns10:Director12023-04-012024-03-31072007101ns10:Director12022-04-012023-03-31072007101ns10:Director12024-03-31072007101ns10:Director12023-03-31
REGISTERED NUMBER: 07200710 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st March 2024

for

Raine Anaesthetic Enterprises Ltd

Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)






Contents of the Financial Statements
for the Year Ended 31st March 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Balance Sheet
31st March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 37,789 44,087
Tangible assets 5 49,178 1,129
86,967 45,216

CURRENT ASSETS
Cash at bank 260,782 251,275

CREDITORS
Amounts falling due within one year 6 38,392 66,880
NET CURRENT ASSETS 222,390 184,395
TOTAL ASSETS LESS CURRENT
LIABILITIES

309,357

229,611

PROVISIONS FOR LIABILITIES 567 215
NET ASSETS 308,790 229,396

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 308,690 229,296
SHAREHOLDERS' FUNDS 308,790 229,396

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18th November 2024 and were signed on its behalf by:




Dr G J Raine - Director


Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Notes to the Financial Statements
for the Year Ended 31st March 2024

1. COMPANY INFORMATION

Raine Anaesthetic Enterprises Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07200710

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Goodwill
Franchise costs, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost
Motor Vehicles - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Franchise
costs
£   
COST
At 1st April 2023
and 31st March 2024 125,970
AMORTISATION
At 1st April 2023 81,883
Amortisation for year 6,298
At 31st March 2024 88,181
NET BOOK VALUE
At 31st March 2024 37,789
At 31st March 2023 44,087

Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1st April 2023 3,822 - 3,822
Additions 2,327 58,350 60,677
At 31st March 2024 6,149 58,350 64,499
DEPRECIATION
At 1st April 2023 2,693 - 2,693
Charge for year 472 12,156 12,628
At 31st March 2024 3,165 12,156 15,321
NET BOOK VALUE
At 31st March 2024 2,984 46,194 49,178
At 31st March 2023 1,129 - 1,129

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Corporation tax payable 7,519 22,289
PAYE creditor 160 285
Directors' current accounts 28,386 44,306
Accrued expenses 2,327 -
38,392 66,880

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
50 Ordinary A £1 50 50
50 Ordinary B £1 50 50
100 100

The A Shares confer on the holders the right to vote upon any resolution proposed at any
general meeting of the company.

The B Shares do not confer on the holders the right to vote upon any resolution proposed at
any general meeting of the company.

The A and B Shares rank pari passu in respect of dividend and capital distribution rights.

Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2024

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st March 2024 and 31st March 2023:

31.3.24 31.3.23
£    £   
Dr G J Raine
Balance outstanding at start of year (44,305 ) (43,470 )
Amounts advanced 16,232 15,420
Amounts repaid (312 ) (16,255 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (28,385 ) (44,305 )

The loan is repayable on demand and no interest was charged during the year.

9. CONTROL

The ultimate controlling party is Dr G Raine by virtue of holding 100% of the voting rights.